Viracta Therapeutics (VIRX) Competitors

Aspira Women's Health (NASDAQ:AWH) and Viracta Therapeutics (NASDAQ:VIRX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their community ranking, profitability, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, risk and valuation.

Do insiders & institutionals have more ownership in AWH or VIRX?

12.2% of Aspira Women's Health shares are owned by institutional investors. Comparatively, 31.4% of Viracta Therapeutics shares are owned by institutional investors. 4.3% of Aspira Women's Health shares are owned by company insiders. Comparatively, 10.7% of Viracta Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Does the MarketBeat Community believe in AWH or VIRX?

Viracta Therapeutics received 15 more outperform votes than Aspira Women's Health when rated by MarketBeat users. Likewise, 70.73% of users gave Viracta Therapeutics an outperform vote while only 16.87% of users gave Aspira Women's Health an outperform vote.

Company	Underperform	Outperform
Aspira Women's Health	Outperform Votes 14 16.87%	Underperform Votes 69 83.13%
Viracta Therapeutics	Outperform Votes 29 70.73%	Underperform Votes 12 29.27%

Is AWH or VIRX more profitable?

Viracta Therapeutics has a net margin of 0.00% compared to Aspira Women's Health's net margin of -165.07%. Aspira Women's Health's return on equity of 0.00% beat Viracta Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aspira Women's Health	-165.07%	N/A	-267.23%
Viracta Therapeutics	N/A	-1,899.61%	-114.21%

Which has more volatility & risk, AWH or VIRX?

Aspira Women's Health has a beta of 2.01, suggesting that its stock price is 101% more volatile than the S&P 500. Comparatively, Viracta Therapeutics has a beta of 1.02, suggesting that its stock price is 2% more volatile than the S&P 500.

Does the media prefer AWH or VIRX?

In the previous week, Aspira Women's Health had 1 more articles in the media than Viracta Therapeutics. MarketBeat recorded 1 mentions for Aspira Women's Health and 0 mentions for Viracta Therapeutics. Aspira Women's Health's average media sentiment score of 1.87 beat Viracta Therapeutics' score of 0.00 indicating that Aspira Women's Health is being referred to more favorably in the media.

Company	Overall Sentiment
Aspira Women's Health	Very Positive
Viracta Therapeutics	Neutral

Do analysts prefer AWH or VIRX?

Aspira Women's Health currently has a consensus price target of $5.50, indicating a potential upside of 6,607.32%. Viracta Therapeutics has a consensus price target of $4.06, indicating a potential upside of 19,337.80%. Given Viracta Therapeutics' higher possible upside, analysts plainly believe Viracta Therapeutics is more favorable than Aspira Women's Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aspira Women's Health	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Viracta Therapeutics	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50

Which has better valuation & earnings, AWH or VIRX?

Aspira Women's Health has higher revenue and earnings than Viracta Therapeutics. Aspira Women's Health is trading at a lower price-to-earnings ratio than Viracta Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aspira Women's Health	$9.18M	0.27	-$16.69M	-$0.98	-0.08
Viracta Therapeutics	N/A	N/A	-$51.06M	-$1.10	-0.02

Summary

Viracta Therapeutics beats Aspira Women's Health on 9 of the 17 factors compared between the two stocks.